INDP: Indaptus Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Indaptus Therapeutics (INDP) bakterial texnologiyalar orqali immun aktivatsiyaning innovatsion usuli yordamida sezilarli narx belgilash imkoniyatini saqlab qolmoqda. PEG o'sish aksiyalari skrineri ushbu potensial dinamikasini aniq ko'rsatadi, bunda parametr qiymati 0.00 ga tengdir. Biroq, rivojlanishning erta bosqichi va likvidlikning yetishmasligi ma'lum xatarlarni yuzaga keltiradi. Biznes asosi hozirda birlamchi klinik sinovlar va tor doiradagi tadqiqot ittifoqlariga tayanadi.
Indaptus Therapeutics (INDP) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Indaptus Therapeutics|INDP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi indaptusrx.com|INDP - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Indaptus|INDP - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Indaptus Therapeutics|Shoshilinch likvidlik koeffitsiyenti indaptusrx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
INDP - Sof foyda|Sof foyda prognozi Indaptus Therapeutics|INDP - P/E multiplikatori|Forvard P/E multiplikatori Indaptus Corp|INDP - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Indaptus|INDP - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Indaptus Therapeutics|INDP - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi indaptusrx.com|INDP - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Indaptus Therapeutics
Kompaniyaning umumiy tahlili:INDP - Indaptus Therapeutics Inc
Indaptus Therapeutics (INDP) o'zining shaxsiy o'simta immunoterapiya texnologiyasini ishlab chiqmoqda, uning kelgusidagi daromadliligi bevosita klinik sinovlar natijalariga bog'liq. PEG ko'rsatkichi foyda birligining tannarxini uning o'sish sur'atiga nisbatan o'lchaydi, bu esa hisoblangan PEG darajasi birdan past bo'lganda aktivning qadrini past baholanganini aniqlash va baholash cho'qqisidagi haddan tashqari qizigan biznesni sotib olishdan qochish imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TRML|PGEN (Precigen) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PHAR (Pharming Group NV)|PEG multiplikatori NKTR|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|IMNM (immunome.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|GOSS: Narx-foyda va o‘sish multiplikatori|KalVista Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp (PVLA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|enGene Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati RAPT (rapt.com)|Aerovate - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences Ltd. (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|VTYX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori THTX|PEG multiplikatori avalotx.com (AVTX)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda zurabio.com|ATYR (aTyr Pharma, Inc.) - Narx-foyda va o‘sish multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori IMA|STTK (Shattuck Therapeutics) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori EQ|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|PEG multiplikatori IMUX (Immunic)|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati X4 Pharmaceuticals Inc. XFOR|ACET: PEG multiplikatori|CELU - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BRNS (barinthusbio.com)|PEG multiplikatori KZR|SAB Biotherapeutics Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV (Enlivex Therapeutics Ltd) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati GOVX|EDSA: PEG multiplikatori|iBio Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|PEG multiplikatori XTL Bio|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Aptevo Therapeutics Inc. APVO|AIM - Narx-foyda va o‘sish multiplikatori|Aditxt Corp - PEG multiplikatori|GRI - PEG multiplikatori|XRTX (XORTX Therapeutics Inc.) - Narx-foyda va o‘sish multiplikatori|reshapelifesciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
